Public Profile

American Biotech Labs

American Biotech Labs, headquartered in the United States, is a pioneering force in the biotechnology industry, specialising in advanced silver-based products. Founded in 1998, the company has established itself as a leader in the development of innovative health solutions, particularly through its flagship product, Silver Biotics. This unique formulation harnesses the power of silver to provide antimicrobial benefits, setting it apart in a crowded market. With a strong presence across North America and expanding operations internationally, American Biotech Labs has achieved significant milestones, including numerous patents and certifications that underscore its commitment to quality and efficacy. The company’s dedication to research and development has positioned it as a trusted name in health and wellness, making it a go-to choice for consumers seeking effective, science-backed solutions.

DitchCarbon Score

How does American Biotech Labs's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

3

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

6

Industry Benchmark

American Biotech Labs's score of 3 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.

26%

American Biotech Labs's reported carbon emissions

American Biotech Labs, headquartered in the US, currently does not have publicly available data on its carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This absence of data suggests that the company may still be in the early stages of formalising its climate commitments or reporting practices. In the context of the biotechnology industry, many companies are increasingly focusing on sustainability and setting ambitious targets to reduce their carbon footprints. However, without specific information from American Biotech Labs, it is unclear what steps they are taking towards climate action or emissions reduction.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. American Biotech Labs's primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. American Biotech Labs is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

American Biotech Labs is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Health Services

HNS

MX
Health Services
Updated 10 days ago

Quantic Group Ltd.

US
Health Services
Updated 10 days ago

Best Formulations

US
Health Services
Updated 10 days ago

Chordate Medical

SE
Health Services
Updated 10 days ago

CorEvitas

US
Health Services
Updated 4 days ago

EDQM

DE
Health Services
Updated 8 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers